In clear (ccRCC), ACOT11 has been identified as a diagnostic marker wherein mRNA level of ACOT11 was decreased compared to those in normal kidneys (Luo et al., 2016). This evidence concerns the gene ACOT11 and nonpapillary renal cell carcinoma.